Butterfly Network (BFLY) Q2 2026: Revenue Jumps 40%, Guidance Raised
As seen on the 24/7 Wall St. homepage on July 30, 2026.
Butterfly Network crushed Q2 with $32.6M in revenue, up 40% year over year, while its licensing arm drove gross margins to 71.4%, widening the path to profitability and prompting a full-year guidance hike to $119M to $123M in sales.
Continue ReadingShow less
Butterfly Network posted $32.6 million in Q2 2026 revenue, a 40% increase from the $23.4 million it reported in the same quarter a year earlier and well above the $29.2 million Wall Street had expected — a beat of roughly 12%. The EPS result was also notably cleaner than anticipated, coming in at -$0.01 against a consensus estimate of -$0.04, a beat of nearly 73%.
A standout detail beneath the top-line number is the gross margin expansion driven by the company's licensing arm, which pushed margins to 71.4%. That kind of margin profile is unusual for a medical-device company and is central to the argument that Butterfly Network can close the remaining gap to profitability without a proportional ramp in costs.
Sponsored
Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.
Management responded to the strong quarter by raising full-year revenue guidance to a range of $119 million to $123 million. For context, the company's trailing quarterly revenue had been largely flat in the low-to-mid $20 million range before a step-up in Q4 2025 to $31.5 million, making Q2 2026's $32.6 million the highest single-quarter revenue figure in at least the past nine quarters of available data.